Gaining 'Insight' on Cardiac Insight’s Recent Surge
Let’s Talk Medtech spoke with Dave Hadley, Phd, Senior VP of Research & Development of Cardiac Insight, about the company and the exploding ECG market.
May 26, 2021
Cardiac Insight is seeing a major uptick in ECG screenings. The Seattle, WA-based company reported there was more than a 70% surge in sales of the Cardea 20/20 ECG in 1Q21.
Let’s Talk Medtech recently spoke with Dave Hadley, Phd, Senior VP of Research & Development. He is the inventor of Cardea 20/20, about the surge and recent interest in the ECG market. Dr. Hadley has more than 30 years of hands-on experience blending customer needs with information technology through research and development.
Cardiac Insight was named a finalist for this year’s Medical Design Excellence Awards.
Click here to access the most recent episode of Let's Talk Medtech.
About the Author
You May Also Like